•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Ardmore Shipping: The War Is The Wrong Reason To Own It - Buy
July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys
Asos eyes profit boost from sale of Atlanta warehouse
Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation
Ardmore Shipping Exercises Newbuilding Options
13 Lucky Dogs: June Graham Value All-Stars (GVAS)
2 Overlooked Oil Stocks to Buy Now Before They Soar
M&S buys mothballed fulfilment centre from Asos for £67m
3 Small-Cap Stocks to Buy Before May 15
Ardmore Shipping Q1 Earnings Call Highlights
Ardmore Shipping: Doubling The Payout Turns It Into A Buy (Ratings Upgrade)
Ardmore Shipping Corporation (ASC) Q1 2026 Earnings Call Transcript
Ardmore Shipping Corporation Announces Financial Results For The Three Months Ended March 31, 2026
Ardmore Shipping Announces First Quarter 2026 Conference Call and Webcast
Ardmore Shipping Provides Update on Fleet Investment, Dividend Policy, and Vessel Sale
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
Asos climbs as profit margins show improvement, with analysts wanting more stability
A Look at Ardmore Shipping Corp (ASC) After 4.8% Gain -- GF Value $9.16 vs Price $16.24
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update